EPTIS
EPTIS
BAM Logo
List%20all%20PT%20schemes%20from%20provider%20%22UK%20NEQAS%20for%20Leucocyte%20Immunophenotyping%22

Search a Proficiency Testing (PT) scheme in the database

Reset

Country
Testing fields
Product groups
Accreditation
Page 1 of 2 (Hits 1 to 20 of 24)
ID
ID
Country
Country
PT provider
PT provider
PT scheme
PT scheme
Last changed
Last changed
146052 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 Kinase Domain Variant (Mutation) Status BCR::ABL1 Kinase Domain Variant (Mutation) Status 2024-04-19
PT provider ID (120044)

146072 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Leukaemia Immunophenotyping (Part 1) [Leukaemia Immunophenotyping (Part 1)] Leukaemia Immunophenotyping (Part 1) [Leukaemia Immunophenotyping (Part 1)] 2022-06-24
PT provider ID (120044)

941705 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for AML by Molecular Methods (not accredited) Measurable Residual Disease for AML by Molecular Methods (not accredited) 2022-10-28
PT provider ID (120044)

146057 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping KIT p.Asp816Val (D816V) Mutation Status for Mast cell disease KIT p.Asp816Val (D816V) Mutation Status for Mast cell disease 2024-04-19
PT provider ID (120044)

146062 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 Minor Quantification BCR::ABL1 Minor Quantification 2024-04-19
PT provider ID (120044)

495789 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited) [Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)] Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited) [Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)] 2022-02-11
PT provider ID (120044)

941730 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Myeloproliferative Neoplasms Diagnostic Testing (partially accredited) Myeloproliferative Neoplasms Diagnostic Testing (partially accredited) 2024-05-03
PT provider ID (120044)

146095 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Low Level Leucocyte Enumeration [Low Level Leucocyte Enumeration] Low Level Leucocyte Enumeration [Low Level Leucocyte Enumeration] 2022-06-24
PT provider ID (120044)

146015 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 and AML Translocation Identification BCR::ABL1 and AML Translocation Identification 2024-05-03
PT provider ID (120044)

287270 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for CLL by Flow Cytometry (not accredited) Measurable Residual Disease for CLL by Flow Cytometry (not accredited) 2022-02-11
PT provider ID (120044)

146027 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia 2018-08-23
PT provider ID (120044)

146400 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Immune Monitoring Immune Monitoring 2024-05-03
PT provider ID (120044)

146407 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping CD34+ Stem Cell Enumeration CD34+ Stem Cell Enumeration 2024-05-03
PT provider ID (120044)

146080 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Leukaemia Diagnostic Interpretation (Part 2) [Leukaemia Diagnostic Interpretation (Part 2)] Leukaemia Diagnostic Interpretation (Part 2) [Leukaemia Diagnostic Interpretation (Part 2)] 2022-06-24
PT provider ID (120044)

287280 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for AML by Flow Cytometry (not accredited) [Measurable Residual Disease for AML by Flow Cytoemtry (not accredited)] Measurable Residual Disease for AML by Flow Cytometry (not accredited) [Measurable Residual Disease for AML by Flow Cytoemtry (not accredited)] 2022-02-11
PT provider ID (120044)

146101 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for ALL by Flow Cytometry Measurable Residual Disease for ALL by Flow Cytometry 2022-02-11
PT provider ID (120044)

288363 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Immune Monitoring Alternative Technologies Immune Monitoring Alternative Technologies 2018-08-23
PT provider ID (120044)

146032 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Post-Stem Cell Transplant Chimerism Monitoring Post-Stem Cell Transplant Chimerism Monitoring 2018-08-23
PT provider ID (120044)

146106 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Paroxysmal Nocturnal Haemoglobinuria Paroxysmal Nocturnal Haemoglobinuria 2024-04-26
PT provider ID (120044)

495801 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Cerebrospinal Fluid (CSF) Immunophenotyping Cerebrospinal Fluid (CSF) Immunophenotyping 2018-08-23
PT provider ID (120044)

Page 1 of 2 (Hits 1 to 20 of 24)
Disclaimer & Privacy Policy
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5